Alethea Capital Management, LLC Cidara Therapeutics, Inc. Transaction History

Alethea Capital Management, LLC

$122 Million
Q1 2024

A detailed history of Alethea Capital Management, LLC transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Alethea Capital Management, LLC holds 1,598,492 shares of CDTX stock, worth $17.9 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

1,598,492

Previous 1,627,670 1.79%

Holding current value

$17.9 Million

Previous $1.29 Million 14.4%

% of portfolio

1.21%

Previous 1.48%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.64 - $0.92 $18,673 - $26,843	-29,178 Reduced 1.79%	1,598,492 $1.47 Million
Q2 2023 Aug 14, 2023	SELL	$1.01 - $1.42 $50,019 - $70,324	-49,524 Reduced 2.95%	1,627,670 $1.84 Million
Q2 2022 Aug 15, 2022	SELL	$0.43 - $0.91 $112,690 - $238,485	-262,072 Reduced 13.51%	1,677,194 $819,000
Q1 2022 May 13, 2022	BUY	$0.67 - $1.39 $1,488 - $3,088	2,222 Added 0.11%	1,939,266 $1.62 Million
Q4 2021 Feb 14, 2022	BUY	$1.18 - $2.18 $902,700 - $1.67 Million	765,000 Added 65.27%	1,937,044 $2.46 Million

Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.7 $15,732 - $22,715	8,413 Added 0.72%	1,172,044 $2.37 Million
Q1 2021 May 14, 2021	BUY	$2.06 - $3.01 $19,570 - $28,594	9,500 Added 0.82%	1,163,631 $3.1 Million
Q4 2020 Feb 12, 2021	SELL	$1.99 - $3.25 $312 - $510	-157 Reduced 0.01%	1,154,131 $2.31 Million
Q3 2020 Nov 16, 2020	BUY	$2.85 - $4.1 $358,812 - $516,185	125,899 Added 12.24%	1,154,288 $3.29 Million
Q2 2020 Aug 11, 2020	BUY	$2.39 - $4.0 $319,146 - $534,136	133,534 Added 14.92%	1,028,389 $3.8 Million
Q1 2020 May 11, 2020	BUY	$1.74 - $4.26 $575,143 - $1.41 Million	330,542 Added 58.57%	894,855 $2.22 Million
Q1 2019 May 06, 2019	BUY	$2.35 - $3.27 $192,596 - $267,996	81,956 Added 16.99%	564,313 $1.5 Million
Q4 2018 Jan 23, 2019	BUY	$2.1 - $4.5 $94,500 - $202,500	45,000 Added 10.29%	482,357 $1.13 Million
Q3 2018 Oct 29, 2018	BUY	$3.7 - $5.25 $1.21 Million - $1.72 Million	328,263 Added 300.9%	437,357 $1.92 Million
Q2 2018 Jul 17, 2018	BUY	$3.75 - $6.05 $116,992 - $188,747	31,198 Added 40.05%	109,094 $567,000
Q1 2018 Apr 18, 2018	BUY	$4.0 - $8.15 $102,560 - $208,966	25,640 Added 49.07%	77,896 $312,000
Q4 2017 Feb 14, 2018	BUY	$6.35 - $8.75 $331,825 - $457,240	52,256	52,256 $355,000

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.2M

Call Options Held

2.7K

Put Options Held

100

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $786M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.

Account

Alethea Capital Management, LLC Cidara Therapeutics, Inc. Transaction History